Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Classement en actions #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Prix de l'action
$4.00
Dernière synchronisation: 2026-08-20
Capitalisation boursière
$75.37M
Changement (1 jour)
0.00%
Changement (1 an)
12.99%
Pays
US
Échange RetinalGenix Technologies Inc. (RTGN)

Catégorie

Ratio P/B pour RetinalGenix Technologies Inc. (RTGN)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de RetinalGenix Technologies Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour RetinalGenix Technologies Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
- -
DE